Steve Kelsey
Fortune : 60 M $ au 31/08/2026
Fortune : 60 M $ au 31/08/2026
Stephen M.
Kelsey is an Independent Director at Circle Pharma, Inc. since 2022 and an Independent Director at Jiya Acquisition Corp.
since 2020.
Former positions include Director-Clinical Affairs at Pharmacia Corp.
in 2002, Vice President-Clinical Hematology & Oncology at Genentech, Inc. in 2009, Chief Medical Officer & Executive Vice President at Geron Corp.
from 2009 to 2013, Senior Vice President-New Projects at Medivation LLC (California) from 2013 to 2014, President at Onkaido Therapeutics LLC from 2014 to 2017, and President-Research & Development at Revolution Medicines, Inc. from 2017 to 2026.
Education includes undergraduate, graduate, and doctorate degrees from the University of Birmingham.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 291 876 ( 0,14 % ) | 60 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| JIYA ACQUISITION CORP. | Directeur/Membre du Conseil | 18/11/2020 |
Circle Pharma, Inc.
Circle Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Directeur/Membre du Conseil | 15/12/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Directeur Technique/Scientifique/R&D | 01/07/2026 |
Onkaido Therapeutics LLC
Onkaido Therapeutics LLC Pharmaceuticals: MajorHealth Technology Offers advancement of oncology products for previously undruggable targets and as a superior alternative to existing drug modalities | President | 01/03/2017 |
| MEDIVATION INC | Corporate Officer/Principal | 01/06/2014 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/04/2009 |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Directeur Technique/Scientifique/R&D | 01/06/2002 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Pharmacia Corp.
Pharmacia Corp. Pharmaceuticals: MajorHealth Technology Researches, manufactures and sells pharmaceuticals | Health Technology |
University of Birmingham
University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medivation LLC (California)
Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Circle Pharma, Inc.
Circle Pharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
Onkaido Therapeutics LLC
Onkaido Therapeutics LLC Pharmaceuticals: MajorHealth Technology Offers advancement of oncology products for previously undruggable targets and as a superior alternative to existing drug modalities | Health Technology |
Revolution Medicines, Inc.
Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
Jiya Acquisition Corp.
Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national